New frontiers in sickle cell disease: The role of antiviral therapies and emerging drugs in managing viral infections

doi:10.5501/wjv.v14.i2.101693

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

HTML

Figures (1-3)

Tables (1-2)

Sum=11

Jun 25, 2025 (publication date) through Jun 23, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Virology

ISSN

2220-3249

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Virol. Jun 25, 2025; 14(2): 101693
Published online Jun 25, 2025. doi: 10.5501/wjv.v14.i2.101693

Open in New Tab Full Size Figure Download Figure

Figure 1 Historical management of sickle cell disease and viral infections. COVID-19: Coronavirus disease 2019; CRISPR-cas9: Clustered regularly interspaced short palindromic repeats; FDA: Food and Drug Administration; SCD: Sickle cell disease; VOC: Vaso-occlusive crisis.

Open in New Tab Full Size Figure Download Figure

Figure 2 Mechanisms of viral infection-related exacerbation in sickle cell disease. Hb: Hemoglobin; IL: Interleukin; NO: Nitric oxide; RBCs: Red blood cells; ROS: Reactive oxygen species; TNF-α: Tumor necrosis factor-alpha.

Open in New Tab Full Size Figure Download Figure

Figure 3 Treatments and prophylaxis for viral infections in sickle cell disease. COVID-19: Coronavirus disease 2019; IG: Immunoglobulin; SARS-CoV 2: Severe acute respiratory syndrome-coronavirus 2.

Citation: Sahu T, Jagzape AT, Sinha M, Sinha R, Verma HK. New frontiers in sickle cell disease: The role of antiviral therapies and emerging drugs in managing viral infections. World J Virol 2025; 14(2): 101693
URL: https://www.wjgnet.com/2220-3249/full/v14/i2/101693.htm
DOI: https://dx.doi.org/10.5501/wjv.v14.i2.101693